La Grande Observer

New Study Demonstrates Potential for Enhanced Accuracy of Blood Cultures with Steripath® Initial Specimen Diversion Device® (ISDD®) for Central Line Draws

SEATTLE, March 5, 2025 /PRNewswire/ — Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device ® (ISDD ®) technology, today announced groundbreaking new findings from an ...
FOX8 Cleveland

Newly Released CLSI National Blood Culture Guidelines Identify Best Practices and Evidence-Based Technology Solutions Such as Steripath® to Improve Patient Safety and Outcomes

Steripath ® Initial Specimen Diversion Device ®, a clinically proven solution, enables hospitals to meet the new goal of 1% blood culture contamination as published in CLSI's M47 Principles and ...
FOX31 Denver

Stanford Health Care Achieves Zero Blood Culture Contaminations and Near Elimination of False-Positive CLABSIs in Large-Scale Study Using the Steripath® Initial Specimen ...

Peer-reviewed study published in leading medical journal constitutes the largest controlled clinical dataset ever documented with zero blood culture contamination events. Importantly, the study also ...